Outpatient versus inpatient treatment for patients with acute pulmonary embolism: an international, open-label, randomised, non-inferiority trial.

Autoria(s): Aujesky D.; Roy P.M.; Verschuren F.; Righini M.; Osterwalder J.; Egloff M.; Renaud B.; Verhamme P.; Stone R.A.; Legall C.; Sanchez O.; Pugh N.A.; N'gako A.; Cornuz J.; Hugli O.; Beer H.J.; Perrier A.; Fine M.J.; Yealy D.M.
Data(s)

2011
Identificador

http://serval.unil.ch/?id=serval:BIB_565E6DB21332

isbn:1474-547X (Electronic)

pmid:21703676

doi:10.1016/S0140-6736(11)60824-6

isiid:000292659700032
Idioma(s)

en
Fonte

Lancet, vol. 378, no. 9785, pp. 41-48
Palavras-Chave #Acute Disease; Administration, Oral; Ambulatory Care; Anticoagulants/administration & dosage; Anticoagulants/adverse effects; Enoxaparin/administration & dosage; Enoxaparin/adverse effects; Female; Health Resources/utilization; Hemorrhage/chemically induced; Hospitalization; Humans; Injections, Subcutaneous; Length of Stay; Male; Middle Aged; Outcome Assessment (Health Care); Patient Readmission; Patient Satisfaction; Pulmonary Embolism/diagnosis; Pulmonary Embolism/drug therapy; Recurrence
Tipo

info:eu-repo/semantics/article

article
Acesso ao item digital